BAYER AG S/ADR (BAYRY)
Bayer Aktiengesellschaft, commonly known as Bayer AG, functions as a prominent global life sciences company through its various subsidiaries. Its extensive operations are strategically segmented into Pharmaceuticals, Consumer Health, and Crop Science. The Pharmaceuticals division concentrates on developing and marketing prescription medications, with key areas including cardiology and women's healthcare. It also offers specialized therapeutic solutions for oncology, hematology, and ophthalmology, alongside diagnostic imaging equipment, contrast agents, and advanced cell and gene therapies. Bayer's Consumer Health segment provides a wide array of non-prescription (over-the-counter) medicines, medical devices, medicated skincare items, and nutritional supplements. These self-care products address diverse health needs such as dermatology, dietary support, pain relief, cardiovascular risk prevention, digestive issues, allergy management, and cold and cough symptoms. The Crop Science division supports the agricultural sector with chemical and biological crop protection products, genetically enhanced plant traits, seeds, digital farming tools, and solutions for pest and weed control. This segment also manages the breeding, propagation, production, and specialized treatment of seeds, complemented by dedicated customer service for farmers. Bayer is actively involved in numerous strategic collaborations to bolster its research and development pipeline. These partnerships include an agreement with MD Anderson Cancer Center for oncology drug development, a research and licensing deal with Dewpoint Therapeutics, Inc. focused on novel treatments for cardiovascular and gynecological diseases, and collaborations with Exscientia Ltd, Foundation Medicine Inc., Evotec AG, and Arvinas Inc. Additionally, the company maintains strategic research alliances with the University of Oxford for gynecological therapies and with Kyoto University to discover potential new drugs for pulmonary conditions. The company’s products reach a broad market through various distribution channels, including wholesale partners, independent and chain pharmacies, supermarkets, online and other retail outlets, hospitals, and direct sales to agricultural producers. Bayer Aktiengesellschaft was established in 1863 and is headquartered in Leverkusen, Germany.
Sector: Drug Manufacturers - General
Industry: Drug Manufacturers - General
Bayer AG
OTC:BAYRYHealthcare · Drug Manufacturers - General
-0.81%$12.30
Mkt Cap-
Float982.42M
O/S-
Inst Own-
SI<0.1%
Div Yield0.26%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$49B
Net Income-$3.89B
Total Assets$123.75B
Free Cash Flow$2.24B
Debt & Equity
Debt 59%
Equity 41%
Total Debt$41.89B
Total Equity$29.03B
Shares Outstanding
Short Interest
Split History1 split
- 4:1Forward splitSep 20, 20171 share → 4
Balance Sheet Details
Assets$123.75B
Liabilities$94.59B
Accounts Receivable$13.64B
Accounts Payable$7.92B
Inventory$13.85B
PP&E (Net)$14.15B
Goodwill$31.4B
Intangible Assets$23.07B
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 | FY 2002 | FY 2001 | FY 2000 | FY 1999 | FY 1998 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 | 2005-12-31 | 2004-12-31 | 2003-12-31 | 2002-12-31 | 2001-12-31 | 2000-12-31 | 1999-12-31 | 1998-12-31 |
| Revenue | $49B | $52.17B | $53.32B | $56.79B | $49.34B | $46.34B | $48.74B | $44.31B | $39.19B | $52.35B | $51.85B | $47.28B | $44.95B | $44.5B | $40.89B | $39.27B | $34.89B | $36.85B | $36.25B | $32.41B | $30.63B | $33.28B | $31.92B | $32.44B | $32.45B | $33.09B | $30.58B | $31.41B |
| YoY Growth | -6.1% | -2.2% | -6.1% | 15.1% | 6.5% | -4.9% | 10.0% | 13.1% | -25.1% | 1.0% | 9.7% | 5.2% | 1.0% | 8.8% | 4.1% | 12.6% | -5.3% | 1.6% | 11.8% | 5.8% | -8.0% | 4.3% | -1.6% | -0.0% | -1.9% | 8.2% | -2.6% | - |
| Cost of Revenue | $19.99B | $23.81B | $22.11B | $22.24B | $18.82B | $21.42B | $19.55B | $19.04B | $12.74B | $22.72B | $23.68B | $22.68B | $21.66B | $21.33B | $20.12B | $19.14B | $16.94B | $18.42B | $18.3B | $17.1B | $16.81B | $19.44B | $18.81B | $19.62B | $18.55B | $17.47B | $15.21B | $14B |
| Gross Profit | $29.01B | $28.36B | $31.22B | $34.55B | $30.52B | $24.92B | $29.19B | $25.27B | $26.45B | $29.63B | $28.17B | $24.59B | $23.29B | $23.17B | $20.77B | $20.13B | $17.95B | $18.43B | $17.95B | $15.31B | $13.82B | $13.84B | $13.11B | $12.83B | $13.9B | $15.62B | $15.37B | $17.41B |
| Gross Margin | 59.2% | 54.4% | 58.5% | 60.8% | 61.9% | 53.8% | 59.9% | 57.0% | 67.5% | 56.6% | 54.3% | 52.0% | 51.8% | 52.1% | 50.8% | 51.3% | 51.4% | 50.0% | 49.5% | 47.2% | 45.1% | 41.6% | 41.1% | 39.5% | 42.8% | 47.2% | 50.3% | 55.4% |
| Research and Development | $6.2B | $6.95B | $6.01B | $7.36B | $6.06B | $7.98B | $5.98B | $5.87B | $5.04B | $5.22B | $4.79B | $4B | $3.57B | $3.37B | $3.28B | $3.42B | $3.07B | $2.97B | $2.89B | $2.57B | $2.11B | $2.36B | $2.7B | $2.84B | $2.79B | $2.66B | $2.4B | $2.03B |
| Selling, General, and Administrative | $16.46B | $17.84B | $16.72B | $18.94B | $17.15B | $17.83B | $18.09B | $17.33B | $14.71B | $16.49B | $16.19B | $14.28B | $13.39B | $13.27B | $11.94B | $11.7B | $10.68B | $10.92B | $10.69B | $9.1B | $8B | $8.8B | $9.13B | $8.98B | $10.26B | $8.71B | $7.22B | $6.83B |
| Other | -$1.13B | -$154.46M | $8.49B | $45.89M | -$426.45M | -$91.78M | $44.77M | $1.71B | -$137.67M | -$285.42M | -$1.12M | -$97.38M | $719.71M | $623.45M | $896.56M | -$504.8M | $822.69M | $571.96M | -$1.03B | -$1.4B | -$685.15M | -$920.64M | $3.57B | -$692.26M | -$143.41M | -$1.03B | $859.62M | $0 |
| Total Operating Expenses | $21.53B | $24.63B | $31.22B | $26.34B | $22.78B | $25.72B | $24.12B | $24.91B | $19.61B | $21.42B | $20.55B | $18.18B | $17.68B | $17.26B | $16.12B | $17.07B | $14.58B | $14.46B | $15.34B | $12.22B | $10.67B | $11.82B | $14.45B | $11.06B | $12.51B | $12.1B | $10.48B | $8.91B |
| Operating Income (EBIT) | $7.48B | $3.72B | -$167.9M | $7.01B | $7.81B | -$3.29B | $5.64B | $4.38B | $6.61B | $7.88B | $7B | $6.16B | $5.52B | $4.43B | $4.64B | $3.06B | $3.36B | $3.97B | $3.53B | $3.09B | $3.15B | $2.02B | -$1.34B | $1.76B | $1.39B | $3.52B | $3.76B | $3.53B |
| Operating Margin | 15.3% | 7.1% | -0.3% | 12.3% | 15.8% | -7.1% | 11.6% | 9.9% | 16.9% | 15.1% | 13.5% | 13.0% | 12.3% | 10.0% | 11.4% | 7.8% | 9.6% | 10.8% | 9.7% | 9.5% | 10.3% | 6.1% | -4.2% | 5.4% | 4.3% | 10.6% | 12.3% | 11.2% |
| Interest Expense | $1.85B | $2.64B | $2.29B | $2.08B | $1.51B | $1.77B | $2.05B | $1.81B | $974.91M | $1.09B | $1.16B | $1.05B | $1.01B | $1.02B | $1.19B | $772.32M | $912.23M | $1.06B | $1.48B | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $313.94M | $583.16M | $480.18M | $424.21M | $387.28M | $163.32M | $298.16M | $359.3M | $304.45M | $153.34M | $332.43M | $316.76M | $287.66M | $354.82M | $415.26M | $415.26M | $298.85M | $605.54M | $498.09M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | -$10.84B | -$6.34B | -$1.65B | -$4.19B | $2.47B | -$16.02B | -$2.08B | -$3.78B | -$1.48B | -$2.54B | -$1.17B | -$1.22B | -$1.03B | -$2.21B | -$879.77M | -$1.13B | -$1.27B | -$1.33B | -$1.03B | -$875.22M | -$672.87M | -$707.61M | $3.57B | -$692.26M | -$138.38M | -$113.22M | -$583.16M | -$477.94M |
| Income Before Tax (EBT) | -$3.36B | -$2.61B | -$1.81B | $5.23B | $2.29B | -$19.31B | $3.22B | $2.59B | $5.12B | $6.59B | $5.87B | $5.06B | $4.71B | $3.64B | $3.76B | $1.93B | $2.09B | $2.64B | $2.5B | $2.22B | $2.46B | $1.1B | $2.23B | $1.07B | $1.25B | $3.15B | $3.17B | $3.05B |
| Income Tax Expense | $501.01M | $237.29M | $1.48B | $564.13M | $1.15B | -$1.89B | $503.69M | $679.42M | $1.49B | $1.49B | $1.37B | $1.21B | $1.14B | $841.71M | $997.3M | $460.03M | $571.96M | $711.87M | -$80.59M | $508M | $717.28M | $430.18M | -$720.78M | -$119.47M | $172.34M | $1.29B | $915.59M | $1.25B |
| Net Income | -$3.89B | -$2.86B | -$3.29B | $4.65B | $1.12B | -$17.42B | $2.72B | $1.9B | $8.21B | $5.07B | $4.6B | $3.83B | $3.57B | $2.74B | $2.76B | $1.46B | $1.52B | $1.92B | $5.27B | $1.9B | $1.78B | $674.58M | -$1.41B | $1.19B | $1.08B | $1.86B | $2.24B | $1.81B |
| Net Income Margin | -7.9% | -5.5% | -6.2% | 8.2% | 2.3% | -37.6% | 5.6% | 4.3% | 21.0% | 9.7% | 8.9% | 8.1% | 7.9% | 6.2% | 6.8% | 3.7% | 4.4% | 5.2% | 14.5% | 5.9% | 5.8% | 2.0% | -4.4% | 3.7% | 3.3% | 5.6% | 7.3% | 5.8% |
| Supplementary Data | ||||||||||||||||||||||||||||
| EPS | -0.88 | -0.65 | -0.75 | 1.06 | 0.26 | -3.96 | 0.62 | 0.45 | 2.07 | 1.36 | 1.24 | 1.03 | 0.97 | 0.73 | 0.75 | 0.39 | 0.43 | 0.56 | 1.54 | 0.57 | 0.46 | 0.50 | -0.46 | 0.36 | 0.32 | 0.62 | 0.69 | 0.55 |
| Diluted EPS | -0.88 | -0.65 | -0.75 | 1.06 | 0.26 | -3.96 | 0.62 | 0.45 | 2.07 | 1.36 | 1.24 | 1.03 | 0.97 | 0.73 | 0.75 | 0.39 | 0.43 | 0.52 | 1.43 | 0.57 | 0.46 | 0.50 | -0.46 | 0.36 | 0.32 | 0.62 | 0.69 | 0.55 |
| Weighted Average OS | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.76B | 3.49B | 3.33B | 3.31B | 3.31B | 3.31B | 3.31B | 3.31B | 3.31B | 3.30B | 3.06B | 3.06B | 2.99B | 2.92B | 2.92B | 2.70B | 2.93B | 2.92B | 2.93B | 2.92B | 2.92B |
| EBITDA | $11.83B | $9.86B | $4.84B | $11.75B | $7.78B | -$2.8B | $9.78B | $7.06B | $8.66B | $8.74B | $10.75B | $9.67B | $8.96B | $9.42B | $8.05B | $7.04B | $6.51B | $7.01B | $6.57B | $5.23B | $5.2B | $3.79B | $3.95B | $5.48B | $4.63B | $5.92B | $7.38B | $10.23B |
| EBITDA Margin | 24.1% | 18.9% | 9.1% | 20.7% | 15.8% | -6.0% | 20.1% | 15.9% | 22.1% | 16.7% | 20.7% | 20.5% | 19.9% | 21.2% | 19.7% | 17.9% | 18.7% | 19.0% | 18.1% | 16.1% | 17.0% | 11.4% | 12.4% | 16.9% | 14.3% | 17.9% | 24.1% | 32.6% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 | FY 2002 | FY 2001 | FY 2000 | FY 1999 | FY 1998 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 | 2005-12-31 | 2004-12-31 | 2003-12-31 | 2002-12-31 | 2001-12-31 | 2000-12-31 | 1999-12-31 | 1998-12-31 |
| Assets | ||||||||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||||||||
| Cash and Cash Equivalents | $7.46B | $6.93B | $6.61B | $5.79B | $5.11B | $4.69B | $3.56B | $4.54B | $8.49B | $2.13B | $2.08B | $2.07B | $1.86B | $1.9B | $1.98B | $3.18B | $3.05B | $2.34B | $2.83B | $3.26B | $3.68B | $3.99B | $3.05B | $859.73M | $806.37M | $550.59M | $0 | $0 |
| Short-Term Investments | $1.33B | $2.12B | $5.24B | $5.58B | $3.55B | $8.61B | $2.48B | $319M | $1.7B | $3.95B | $304.45M | $172.37M | $154.46M | $379.44M | $3.12B | $1.13B | $410.78M | $709.64M | $374.97M | $78.02M | $260.83M | $32.2M | $143.98M | $32M | $57.87M | $239.54M | $0 | $0 |
| Cash and Short-Term Investments | $8.79B | $9.05B | $11.85B | $11.36B | $8.66B | $13.3B | $6.05B | $4.85B | $10.18B | $6.07B | $2.39B | $2.25B | $2.01B | $2.28B | $5.1B | $4.31B | $3.46B | $3.05B | $3.21B | $3.34B | $3.94B | $4.03B | $3.2B | $891.73M | $864.24M | $790.14M | $0 | $1.93B |
| Accounts Receivable | $13.64B | $11.08B | $10.46B | $11.55B | $11.25B | $10.69B | $13.07B | $13.11B | $9.61B | $12.28B | $11.12B | $10.18B | $8.47B | $10.93B | $12.34B | $9.27B | $8.64B | $8.63B | $8.35B | $8.49B | $8.04B | $7.54B | $9.97B | $10.93B | $8.31B | $8.98B | $7.73B | $8.09B |
| Inventory | $13.85B | $15B | $15.61B | $15.22B | $12.61B | $12.26B | $12.05B | $11B | $7.32B | $9.39B | $9.56B | $9.38B | $7.96B | $7.8B | $7.13B | $6.83B | $6.82B | $7.48B | $6.96B | $6.89B | $6.16B | $6.95B | $6.58B | $7.11B | $6.52B | $6.84B | $5.59B | $6.47B |
| Other Current Assets | $25.73M | $3.25B | $4.11B | $4.09B | $3.89B | $3.67B | $5.27B | $3.6B | $6.54B | $6.32B | $3.59B | $2.9B | $2.8B | $11.17B | $10.24B | $0 | $0 | $8.95M | $94.02M | $12.15B | $8.46B | $1.73B | $0 | $0 | $501.94M | $742.47M | $3.51B | $0 |
| Total Current Assets | $36.3B | $38.55B | $42.04B | $42.26B | $36.46B | $39.91B | $36.44B | $34.62B | $33.66B | $34.08B | $26.66B | $24.88B | $21.3B | $21.25B | $22.46B | $20.5B | $19.02B | $19.21B | $18.65B | $22.38B | $18.56B | $21.86B | $19.75B | $18.92B | $16.2B | $17.35B | $16.84B | $16.49B |
| Long-Term Assets | ||||||||||||||||||||||||||||
| Property, Plant & Equipment Net | $14.15B | $15.06B | $14.91B | $15.31B | $14.2B | $13.11B | $13.97B | $14.49B | $8.54B | $14.68B | $13.85B | $12.79B | $11.21B | $11.04B | $10.99B | $11.01B | $10.53B | $10.62B | $9.87B | $9.93B | $9.31B | $10.27B | $11.1B | $13.93B | $15.19B | $14.98B | $13.42B | $12.28B |
| Goodwill | $31.4B | $33.6B | $36.15B | $44.38B | $44.89B | $40.38B | $43.79B | $42.7B | $16.51B | $18.26B | $18.02B | $18.1B | $11.04B | $10.4B | $0 | $0 | $0 | $0 | $9.2B | $9.21B | $0 | $0 | $0 | $0 | $0 | $1.1B | $0 | $0 |
| Intangible Assets | $23.07B | $24.75B | $26.15B | $27.07B | $29.39B | $29.13B | $38.85B | $41.13B | $13.07B | $15.19B | $16.99B | $17.52B | $9.98B | $10.59B | $12.34B | $9.27B | $8.64B | $8.63B | $16.29B | $17.69B | $8.6B | $6.73B | $7.28B | $9.95B | $5.62B | $4.34B | $7.73B | $8.09B |
| Long-Term Investments | $3.5B | $1.26B | $3.86B | -$2.34B | -$630.17M | -$6.37B | -$263.04M | $2.68B | $4.21B | -$1.98B | $1.07B | $378.32M | $359.3M | $296.61M | -$1.23B | $1.7B | $1.79B | $1.84B | $166.78M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.58B | $1.23B |
| Deferred Tax Assets | $13.21B | $6.9B | $14.05B | $6.27B | $5.13B | $5.25B | $5.12B | $4.79B | $5.5B | $7.11B | $5.24B | $3.34B | $1.79B | $1.77B | $1.47B | $1.31B | $1.06B | $1.29B | $945.81M | $1.35B | $1.9B | $1.38B | $1.45B | $1.08B | $681.83M | $463.6M | $455.56M | $432.05M |
| Other Long-Term Assets | $2.11B | $3.95B | $1.42B | $6.82B | $5.14B | $9.6B | $3.41B | $943.57M | $2.56B | $4.72B | $913.35M | $1.61B | $1.77B | $2.11B | $3.59B | $557.41M | $614.5M | $512.64M | $2.38B | $2B | $2.71B | $2.04B | $2.26B | $2.82B | $3.84B | $2.69B | $242.89M | $308.93M |
| Total Long-Term Assets | $87.45B | $85.52B | $96.54B | $97.51B | $98.12B | $91.1B | $104.88B | $106.73B | $50.38B | $57.97B | $56.07B | $53.73B | $36.14B | $36.21B | $36.6B | $37.15B | $38.11B | $39.57B | $38.85B | $40.18B | $22.51B | $20.42B | $22.09B | $27.79B | $25.33B | $23.56B | $18.18B | $16.39B |
| Other Assets | $0 | $0 | -$8.45B | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $123.75B | $124.07B | $130.13B | $139.77B | $134.59B | $131.01B | $141.32B | $141.35B | $84.04B | $92.05B | $82.74B | $78.61B | $57.44B | $57.46B | $59.06B | $57.65B | $57.13B | $58.78B | $57.51B | $62.56B | $41.07B | $42.28B | $41.84B | $46.71B | $41.53B | $40.91B | $35.01B | $32.88B |
| Liabilities | ||||||||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||||||||
| Accounts Payable | $7.92B | $8.41B | $8.35B | $8.45B | $7.6B | $6.36B | $7.19B | $6.76B | $5.74B | $7.17B | $6.65B | $6B | $5.01B | $4.82B | $4.23B | $3.91B | $3.06B | $2.76B | $2.76B | $2.65B | $2.21B | $1.97B | $2.53B | $2.84B | $2.23B | $2.26B | $1.74B | $1.81B |
| Short-Term Debt | $6.3B | $5.48B | $7.32B | $8.48B | $3.15B | $9.12B | $2.11B | $3.25B | $2.13B | $3.74B | $3.76B | $3.72B | $3.79B | $2.21B | $3.56B | $1.58B | $1.32B | $6.45B | $1.21B | $3.74B | $1.11B | $2.91B | $2.58B | $3.18B | $4.83B | $4.33B | $0 | $0 |
| Current Income Tax Payable | $0 | $1.22B | $692.85M | $1.78B | $1.36B | $3.21B | $1.61B | $1.91B | $940.21M | $1.58B | $1.51B | $555.17M | $536.14M | $475.7M | $85.07M | $69.4M | $104.09M | $72.75M | $62.68M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $4.21B | $4.27B | $2.38B | $4.7B | $16.02B | $19.75B | $10.82B | $1.91B | $7.62B | $9.57B | $9.2B | $9.03B | $7.85B | $6.93B | $5.31B | $4.4B | $3.86B | $4.13B | $4.47B | $1.84B | $2.26B | $0 | $0 | $0 | $0 | $51.25M | $0 | $0 |
| Other Current Liabilities | $14.2B | $16.56B | $11.81B | $15.94B | $4.61B | $24.08B | $4.1B | $14.39B | $6.36B | $8.55B | $7.42B | $6.51B | $5.96B | $6.76B | $6.47B | $6.51B | $5.51B | $6.15B | $7.82B | $9.07B | $4.51B | $6.18B | $5.37B | $4.92B | $3.71B | $4.41B | $3.52B | $3.93B |
| Total Current Liabilities | $36.46B | $32.41B | $32.97B | $39.27B | $32.91B | $41.11B | $25.98B | $25.55B | $15.21B | $20.75B | $19.01B | $17.35B | $15.7B | $14.66B | $14.99B | $12.13B | $10.04B | $15.49B | $11.88B | $17.37B | $10.14B | $11.06B | $10.49B | $10.94B | $10.78B | $11.06B | $7.62B | $8.34B |
| Long-Term Liabilities | ||||||||||||||||||||||||||||
| Long-Term Debt | $34.44B | $38.67B | $41.67B | $36.75B | $39.79B | $36.12B | $40.25B | $41.82B | $13.72B | $17.38B | $17.83B | $19.87B | $5.67B | $7.45B | $8.04B | $10.22B | $11.69B | $10.6B | $13.84B | $12.08B | $8.02B | $7.96B | $7.95B | $8.2B | $3.44B | $2.92B | $0 | $0 |
| Long-Term Unearned Revenue | $233.83M | $383.92M | $522.71M | $673.82M | $906.63M | $831.64M | $846.19M | $1.16B | $1.08B | $908.87M | $1.06B | $1.04B | $220.5M | $241.77M | $11B | $10.24B | $9.65B | $9.42B | $7.9B | $136.54M | $56.7M | $0 | $0 | $0 | $0 | $0 | $191.4M | $194.76M |
| Long-Term Deferred Tax Liabilities | $7.65B | $968.19M | $884.25M | $813.73M | $1.04B | $1.49B | $4.2B | $5.17B | $1.29B | $1.49B | $924.54M | $771.2M | $1.34B | $1.05B | $2.37B | $2.88B | $3.59B | $4.02B | $4.33B | $4.86B | $312.81M | $1.39B | $1.63B | $2.75B | $1.39B | $1.79B | $1.3B | $877.53M |
| Other Long-Term Liabilities | $14.66B | $14.72B | $16B | $17.63B | $21.81B | $15.97B | $15.79B | $15.72B | $11.25B | $15.4B | $14.97B | $16.52B | $10.86B | $12.93B | $530.55M | $457.79M | $381.68M | $409.66M | $382.8M | $13.46B | $10B | $8.02B | $7.99B | $7.5B | $6.84B | $6.54B | $6.27B | $6.47B |
| Total Long-Term Liabilities | $58.13B | $55.8B | $60.13B | $56.94B | $64.55B | $55.54B | $62.15B | $64.15B | $27.57B | $35.6B | $35.25B | $38.63B | $18.46B | $22.01B | $22.5B | $24.37B | $25.88B | $25B | $26.8B | $30.81B | $18.72B | $17.38B | $17.57B | $18.45B | $11.67B | $11.47B | $10.4B | $10.23B |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $94.59B | $88.21B | $93.1B | $96.2B | $97.46B | $96.65B | $88.13B | $89.7B | $42.79B | $56.35B | $54.25B | $55.98B | $34.15B | $36.68B | $37.49B | $36.5B | $35.92B | $40.49B | $38.68B | $48.17B | $28.87B | $28.44B | $28.06B | $29.39B | $22.45B | $22.53B | $18.02B | $18.58B |
| Stockholders' Equity | ||||||||||||||||||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $859.62M |
| Common Stock | $2.81B | $2.82B | $2.82B | $2.82B | $2.82B | $2.82B | $2.82B | $2.67B | $2.37B | $2.37B | $2.37B | $2.37B | $2.37B | $2.37B | $2.37B | $2.37B | $2.37B | $2.19B | $2.19B | $2.19B | $2.09B | $2.09B | $2.09B | $2.09B | $2.1B | $2.1B | $2.09B | $2.09B |
| Retained Earnings | $7.53B | $0 | $13.63B | $19.29B | $14.94B | $14.61B | $0 | $28.8B | $30.05B | $20.59B | $18.56B | $14.52B | $16.58B | $13.28B | $0 | $0 | $0 | $0 | $0 | $0 | $7.16B | $9.79B | $11.71B | $12.48B | $12.12B | $10.15B | $8.92B | $7.97B |
| Comprehensive Income & Other | -$1.74B | $1.47B | -$26.86M | $855.15M | -$1.23B | -$3.7B | $29.65B | -$14.01B | -$12.54B | -$25.09B | -$23.69B | -$22.26B | -$20.64B | -$19.89B | -$19.31B | $18.71B | $18.78B | $16.01B | -$15.21B | -$15.06B | -$16.19B | -$21.52B | -$21.18B | -$19.91B | -$20.57B | -$20.64B | $0 | -$1.1B |
| Other Stockholders' Equity | $18.69B | $32.9B | $20.41B | $21.29B | $19.21B | $16.74B | $50.17B | $19.99B | $8.77B | $10.99B | $6.23B | $5.61B | $4.24B | $5.03B | $19.13B | $18.71B | $18.78B | $16.01B | $16.54B | $12.1B | $2.87B | $1.84B | -$151.98M | $2.61B | $4.76B | $5.86B | $5.79B | $4.01B |
| Total Equity | $29.03B | $35.71B | $36.86B | $43.4B | $36.96B | $34.17B | $52.98B | $51.46B | $41.19B | $33.95B | $27.16B | $22.5B | $23.19B | $20.67B | $21.5B | $21.08B | $21.15B | $18.2B | $18.73B | $14.29B | $12.12B | $13.72B | $13.65B | $17.18B | $18.97B | $18.12B | $16.8B | $14.07B |
| Minority Interest | $129.78M | $153.34M | $169.01M | $171.25M | $165.66M | $195.88M | $201.47M | $191.4M | $67.16M | $1.75B | $1.32B | $125.36M | $96.26M | $111.93M | $66.04M | $70.52M | $60.44M | $86.19M | $97.38M | $94.14M | $89.78M | $123.85M | $137.76M | $134.4M | $109.45M | $265.76M | $197M | $236.17M |
| Total Liabilities and Equity | $123.62B | $123.92B | $129.96B | $139.6B | $134.42B | $130.81B | $141.12B | $141.16B | $83.98B | $90.3B | $81.41B | $78.49B | $57.34B | $57.35B | $58.99B | $57.58B | $57.07B | $58.69B | $57.41B | $62.46B | $40.98B | $42.16B | $41.7B | $46.57B | $41.42B | $40.65B | $34.81B | $32.65B |
| Supplementary Data | ||||||||||||||||||||||||||||
| Total Debt | $41.89B | $45.55B | $50.13B | $46.61B | $44.25B | $46.51B | $43.52B | $45.52B | $14.78B | $20.44B | $21.04B | $21.54B | $8.06B | $9.97B | $12.22B | $12.36B | $13.55B | $17.58B | $15.45B | $16.15B | $9.58B | $10.87B | $10.53B | $11.38B | $8.28B | $7.48B | $5B | $5.29B |
| Net Debt | $34.43B | $38.62B | $43.52B | $40.83B | $39.14B | $41.82B | $39.96B | $40.98B | $6.3B | $18.32B | $18.96B | $19.46B | $6.2B | $8.08B | $10.24B | $9.18B | $10.5B | $15.23B | $12.61B | $12.89B | $5.9B | $6.88B | $7.48B | $10.52B | $7.47B | $6.93B | $5B | $5.29B |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 | FY 2002 | FY 2001 | FY 2000 | FY 1999 | FY 1998 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 | 2005-12-31 | 2004-12-31 | 2003-12-31 | 2002-12-31 | 2001-12-31 | 2000-12-31 | 1999-12-31 | 1998-12-31 |
| Operating Activities | ||||||||||||||||||||||||||||
| Net Income | -$3.89B | -$2.85B | -$3.29B | $4.66B | $1.14B | -$17.42B | $2.72B | $1.92B | $3.64B | $5.1B | $4.5B | $3.85B | $3.57B | $2.79B | $2.77B | $1.47B | $1.52B | $1.92B | $2.58B | $1.71B | $3.15B | $2.02B | -$1.34B | $1.76B | $1.81B | $3.69B | $2.24B | $1.81B |
| Depreciation & Amortization | $4.35B | $9.83B | $4.36B | $4.44B | $4.17B | $14.84B | $4.94B | $3.29B | $2.37B | $2.62B | $3.73B | $3.29B | $3.24B | $3.31B | $3.1B | $3.98B | $3.14B | $3.05B | $3.04B | $2.14B | $2.05B | $2.6B | $5.29B | $3.71B | $2.82B | $2.4B | $2.03B | $1.73B |
| Deferred Income Tax | -$568.74M | $0 | $0 | -$2.31B | -$673.82M | -$3.33B | -$1.5B | -$2.16B | -$226.1M | -$640.24M | -$1.15B | $0 | $0 | $0 | $0 | -$1B | -$139.91M | -$197M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $0 | $0 | $0 | $408.54M | $266.39M | $70.52M | $339.15M | $23.51M | $217.14M | $97.38M | $277.59M | $237.29M | $307.81M | $198.12M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Changes in Working Capital: | ||||||||||||||||||||||||||||
| Accounts Receivable | -$916.01M | $220.5M | $771.2M | $301.09M | -$68.28M | $777.91M | $15.67M | $2.82B | -$20.15M | -$430.93M | -$1.19B | -$1.2B | -$840.59M | -$509.28M | $0 | -$171.25M | -$31.34M | -$149.99M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $510.68M | $583.16M | -$481.3M | -$2.43B | -$193.64M | -$1.01B | -$115.29M | $688.37M | -$327.95M | -$3.36M | -$209.31M | -$829.4M | -$680.53M | -$754.41M | -$269.75M | $236.17M | $676.06M | -$774.56M | -$388.4M | -$173.86M | -$202.24M | -$621.74M | -$55.1M | -$61.87M | $163.54M | -$841.39M | $149.99M | -$420.86M |
| Accounts Payable | -$189.22M | -$145.29M | $91.78M | $685.01M | $955.88M | -$388.4M | $849.55M | $287.66M | $296.61M | $346.98M | $447.72M | $0 | $0 | $0 | $0 | $633.52M | $263.04M | -$40.29M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Working Capital | $7.21B | -$708.52M | -$4.93B | -$1.57B | $488.01M | $10.32B | $879.77M | $3.83B | $330.19M | -$433.17M | -$208.19M | -$678.3M | -$338.03M | $72.75M | $144.39M | $423.1M | -$105.21M | -$923.42M | -$174.61M | $190.82M | $275.95M | -$228.71M | $109.32M | $1.64B | $885.63M | -$362.3M | -$526.07M | -$94.02M |
| Total Working Capital Change | $6.61B | $95.14M | -$4.55B | -$3.02B | $1.18B | $9.7B | $1.63B | $4.52B | $2.24M | -$436.53M | -$417.5M | -$1.51B | -$1.02B | -$681.65M | -$125.36M | $1.12B | $802.54M | -$1.89B | -$563.01M | $16.96M | $73.71M | -$850.46M | $54.21M | $1.58B | $1.05B | -$1.2B | -$376.08M | -$514.88M |
| Other Non-Cash Items | -$1.59B | $1.17B | $9.21B | $3.76B | -$392.4M | $1.62B | $1.06B | $1.27B | $3.1B | $3.43B | -$98.5M | $870.82M | -$1.12M | -$352.58M | -$77.23M | $1.56B | $1.1B | $1.48B | -$259.68M | $837.91M | -$1.35B | -$1.03B | -$321.73M | -$2.1B | -$1.35B | -$1.42B | -$250.72M | $169.01M |
| Net Cash from Operating | $4.91B | $8.25B | $5.73B | $7.94B | $5.7B | $5.49B | $9.19B | $8.86B | $9.1B | $10.17B | $7.71B | $6.5B | $5.79B | $5.07B | $5.66B | $6.46B | $6.02B | $4.04B | $4.79B | $4.7B | $3.92B | $2.74B | $3.68B | $4.95B | $4.33B | $3.47B | $3.64B | $3.19B |
| Investing Activities | ||||||||||||||||||||||||||||
| Capital Expenditures | -$2.67B | -$3.11B | -$3.08B | -$3.3B | -$2.92B | -$2.71B | -$2.97B | -$2.9B | -$2.65B | -$2.89B | -$2.82B | -$2.65B | -$2.41B | -$2.16B | -$1.81B | -$1.69B | -$1.76B | -$1.97B | -$2.08B | -$2.1B | -$1.55B | -$1.4B | -$1.85B | -$2.51B | -$2.93B | -$2.97B | -$2.95B | -$3.03B |
| Acquisitions | $233.3M | -$186.92M | -$551.81M | $2.46B | -$1.51B | $2.14B | $2.39B | -$42.26B | $330.19M | -$17.91M | -$194.76M | -$14.82B | -$1.12B | -$322.36M | $193.64M | $0 | $0 | -$1.81B | -$549.58M | -$16.64B | -$2.45B | -$400.46M | -$80.88M | -$8.71B | -$562.32M | -$4.63B | -$388.4M | -$1.62B |
| Purchases of Investments | -$192.45M | -$280.94M | -$498.09M | -$3.37B | -$447.72M | -$5.26B | -$810.37M | $2.9B | -$350.34M | -$7.09B | -$414.14M | -$198.12M | $0 | -$292.14M | -$3.13B | -$1.25B | -$408.54M | $0 | $184.68M | $0 | -$225.86M | $223.76M | -$92.43M | $2.37B | $583.71M | -$50.05M | $0 | $0 |
| Sales of Investments | $903.1M | $2.88B | $155.58M | $35.82M | $5.26B | $753.29M | $166.78M | $6.4B | $1.73B | $0 | $0 | $0 | $336.91M | $1.49B | $0 | $113.05M | $267.51M | $0 | $810.37M | $0 | $445.11M | $217.98M | $1.84B | $1.04B | $367.33M | $128.71M | $0 | $0 |
| Other Investing Activities | $0 | $877.53M | -$519.36M | $1.51B | $570.84M | $518.24M | $467.87M | -$2.37B | $457.79M | $223.86M | $334.67M | $279.82M | $311.17M | $370.49M | $391.75M | $127.6M | $643.6M | $321.24M | $5.2B | $2.25B | $1.83B | $447.52M | $696.79M | $450.13M | $155.99M | $575.62M | $3.57B | $1.07B |
| Net Cash from Investing | -$1.73B | $183.57M | -$4.49B | -$2.67B | $957M | -$4.56B | -$751.05M | -$38.23B | -$483.54M | -$9.77B | -$3.09B | -$17.39B | -$2.89B | -$915.59M | -$4.35B | -$2.7B | -$1.26B | -$3.46B | $3.57B | -$16.49B | -$1.95B | -$910.73M | $513.7M | -$7.36B | -$2.39B | -$6.95B | $239.53M | -$3.57B |
| Financing Activities | ||||||||||||||||||||||||||||
| Debt Repaid | $2.29B | $5.62B | -$3.64B | $1.09B | $2.74B | -$5B | $4.81B | -$19.94B | $2.77B | $817.09M | $3.28B | -$13.25B | $692.85M | $2.18B | $444.36M | $1.73B | $1.61B | -$1.71B | $6.28B | -$282K | -$564K | $56K | $351.95M | -$3.96B | $41.51M | -$2.31B | -$1.37B | -$1.9B |
| Common Stock Issuance | $0 | $0 | $25.74M | $16.79M | $0 | $0 | $0 | $10.06B | $4.16B | $3.69B | $1.67B | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2.38M | $0 | $0 |
| Common Stock Repurchases | -$15.05M | -$17.91M | -$26.86M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$136.54M | -$146.63M | -$2.66B | -$2.2B | -$2.2B | -$3.08B | -$2.92B | -$2.69B | -$2.65B | -$2.38B | -$2.09B | -$1.95B | -$1.76B | -$1.53B | -$1.39B | -$1.3B | -$1.09B | -$1.26B | -$865.22M | -$598.83M | -$492.49M | -$625.69M | -$741.22M | -$741.33M | -$1.15B | -$1.07B | -$861.86M | -$796.94M |
| Other Financing Activities | $90.34M | -$2.25B | -$1.74B | -$1.4B | -$1.34B | -$1.45B | -$1.66B | -$1.09B | -$991.7M | -$953.64M | -$754.41M | -$408.54M | -$386.16M | -$527.19M | -$642.48M | $435.41M | -$930.14M | -$1.42B | -$1.5B | $21.2M | -$879.26M | -$799.26M | -$874.54M | -$742.39M | -$495.65M | -$380.17M | -$324.6M | -$407.43M |
| Net Cash from Financing | -$2.35B | -$8.03B | -$760M | -$4.72B | -$6.32B | $473.46M | -$9.39B | $26.23B | -$2.11B | -$391.75M | -$4.45B | $10.9B | -$2.84B | -$4.23B | -$2.48B | -$3.62B | -$4.05B | -$977.15M | -$8.65B | $11.42B | -$2.1B | -$851.28M | -$1.97B | $2.48B | -$1.69B | $862.84M | -$1.94B | -$224.98M |
| Forex Effect | $522.23M | -$76.11M | -$207.07M | $125.36M | $39.18M | -$268.63M | $6.72M | -$650.31M | -$155.58M | $30.22M | -$171.25M | $205.95M | -$101.86M | -$7.84M | -$30.22M | -$15.67M | $3.36M | -$92.9M | -$133.2M | -$50.04M | $40.64M | -$50.37M | -$28.44M | -$17.07M | $8.81M | $9.53M | $15.67M | $1.12M |
| Net Change in Cash | $1.36B | $317.88M | $823.8M | $679.42M | $417.5M | $1.13B | -$970.43M | -$3.79B | $6.36B | $44.77M | $6.72M | $213.79M | -$40.29M | -$83.95M | -$1.2B | $128.72M | $706.28M | -$489.13M | -$429.81M | -$418.1M | -$93.56M | $928.07M | $2.2B | $54.4M | $255.37M | -$2.61B | $1.82B | -$629.05M |
| Supplementary Data | ||||||||||||||||||||||||||||
| Operating Cash Flow | $4.91B | $8.25B | $5.73B | $7.94B | $5.7B | $5.49B | $9.19B | $8.86B | $9.1B | $10.17B | $7.71B | $6.5B | $5.79B | $5.07B | $5.66B | $6.46B | $6.02B | $4.04B | $4.79B | $4.7B | $3.92B | $2.74B | $3.68B | $4.95B | $4.33B | $3.47B | $3.64B | $3.19B |
| Capital Expenditure | -$2.67B | -$3.11B | -$3.08B | -$3.3B | -$2.92B | -$2.71B | -$2.97B | -$2.9B | -$2.65B | -$2.89B | -$2.82B | -$2.65B | -$2.41B | -$2.16B | -$1.81B | -$1.69B | -$1.76B | -$1.97B | -$2.08B | -$2.1B | -$1.55B | -$1.4B | -$1.85B | -$2.51B | -$2.93B | -$2.97B | -$2.95B | -$3.03B |
| Free Cash Flow | $2.24B | $5.14B | $2.65B | $4.64B | $2.77B | $2.78B | $6.22B | $5.96B | $6.46B | $7.29B | $4.89B | $3.85B | $3.37B | $2.91B | $3.86B | $4.77B | $4.25B | $2.07B | $2.71B | $2.6B | $2.36B | $1.34B | $1.83B | $2.44B | $1.39B | $498.16M | $695.09M | $162.3M |
| Cash at Beginning | $6.11B | $6.61B | $5.79B | $5.11B | $4.69B | $3.56B | $4.54B | $8.32B | $2.13B | $2.08B | $2.07B | $1.86B | $1.9B | $1.98B | $3.18B | $3.05B | $2.34B | $2.83B | $3.26B | $3.68B | $3.77B | $3.06B | $856.76M | $805.33M | $551M | $3.16B | $1.33B | $1.95B |
| Cash at End | $7.46B | $6.93B | $6.61B | $5.79B | $5.11B | $4.69B | $3.56B | $4.54B | $8.49B | $2.13B | $2.08B | $2.07B | $1.86B | $1.9B | $1.98B | $3.18B | $3.05B | $2.34B | $2.83B | $3.26B | $3.68B | $3.99B | $3.05B | $859.73M | $806.37M | $550.59M | $3.15B | $1.33B |